NOTE TO READERS: When this project lost substantial funding at the end of 2018, I lost the ability to continue publishing criteria-driven news story reviews and PR news release reviews - once the bread-and-butter of the site going back to 2006. The 3,200 archived reviews, while still educational, are getting old and difficult for me to technically maintain on the back end of the website. So I am announcing that I plan to remove these reviews from the site by April 1, 2021. The blog and the toolkit - two of the most popular features on the site - will remain. If you wish to peruse the reviews before they disappear, please do so by the end of March 2021. After that date you may still be able to access them via the Internet Archive Wayback Machine - https://archive.org/web/.

Category: News from scientific meetings

1 7/27/2018

Many questions linger about this possible Alzheimer’s treatment. So why the avalanche of news coverage?

1 7/26/2018

Intensive blood pressure control and ‘dementia’: another mad rush to report incomplete SPRINT findings

7/24/2018

Motherhood affects Alzheimer’s risk? Here’s what you need to know

6/6/2018

Questions about a ‘simple blood test’ to screen for cancer prompt revealing answer: It’s complicated

6/5/2018

A hyped news release gets revised at ASCO: Did it lead to improved coverage from journalists?

6/1/2018

As world’s largest cancer conference gets underway, keep these three tweets in mind

2 5/18/2018

ASCO pumps up a one-sided view of lung cancer screening: Here’s what most of the coverage missed

5/16/2018

ASCO 2018: How a major medical meeting uses embargoes to shape the news, and what the consequences may be

1 3/12/2018

LifeVest study results: PR spin machine in full effect at American College of Cardiology meeting

2/28/2018

The DASH diet fights depression? Superficial stories rehash news release on unpublished study

Blog

Opinions on other issues in news, journals, PR, advertising, marketing

@HealthNewsRevu

Retweet on TwitterHealthNewsReview.org Retweeted
AKECasselsAlan Cassels@AKECassels·

Puleeeeease... this 'game changer' weight loss drug causes more nausea and vomiting than a placebo. Some game, some change. My friend Gary would spank you for using the eighth word medical reporters should never, ever use. @garyschwitzer @thackerpd
https://www.healthnewsreview.org/toolkit/just-journalists-writing-tips-case-studies/7-words-and-more-you-shouldnt-use-in-medical-news/ https://twitter.com/OttawaCitizen/status/1361426796126830597

Reply on Twitter 1361431489326407680Retweet on Twitter 13614314893264076802Like on Twitter 13614314893264076805Twitter 1361431489326407680
Retweet on TwitterHealthNewsReview.org Retweeted
RxISKRxISK@RxISK·

A scary @statnews Op-Ed warns that govt attempts to rein in Pharma may cut off access to "life-changing" drugs.

It takes @garyschwitzer to let us know: the author spent 10 years as Pfizer's public-policy chief. https://twitter.com/garyschwitzer/status/1360325022578053123

Reply on Twitter 1361420459284131843Retweet on Twitter 13614204592841318434Like on Twitter 13614204592841318438Twitter 1361420459284131843
HealthNewsRevuHealthNewsReview.org@HealthNewsRevu·

.@TranspariMED criticizes STAT op-ed for not disclosing pharma funding of author’s institute - similar to criticism we’ve made of STAT op-eds in the past. @transparify @ThinkTankWatch @icer_review https://www.healthnewsreview.org/2021/02/transparency-watchdog-criticizes-stats-non-disclosure-on-pro-pharma-op-ed/

Reply on Twitter 1360214949704982532Retweet on Twitter 13602149497049825323Like on Twitter 13602149497049825328Twitter 1360214949704982532
View More

Categories

View More

Tags